Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Head & Neck 5Other 3Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 550Head and Neck Neoplasms 490Carcinoma, Non-Small-Cell Lung 338Melanoma 217Colorectal Neoplasms 206Ovarian Neoplasms 174Neoplasms 171Breast Neoplasms 168Stomach Neoplasms 141Carcinoma, Renal Cell 133Uterine Cervical Neoplasms 129Neoplasm Metastasis 129Triple Negative Breast Neoplasms 125Lung Neoplasms 118Pancreatic Neoplasms 117Esophageal Neoplasms 107Thyroid Neoplasms 95Endometrial Neoplasms 93Urinary Bladder Neoplasms 92Prostatic Neoplasms 88Sarcoma 81Carcinoma, Squamous Cell 81Carcinoma, Transitional Cell 75Small Cell Lung Carcinoma 74Carcinoma, Hepatocellular 65Recurrence 53Nasopharyngeal Carcinoma 52Carcinoma 47Colonic Neoplasms 46Cholangiocarcinoma 43

Interventions

avasopasem manganese 1Radiotherapy 1Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Oral Ulcer × Head & Neck × Clear all
NCT03689712 2023-10-24

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Galera Therapeutics, Inc.

Phase 3 Completed
455 enrolled 11 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

NCT04648020 2023-05-31

VOICE

Monopar Therapeutics

Phase 2/3 Terminated
190 enrolled
Head & NeckOther

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

NCT03239834 2021-08-12

Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making

Vigilant Biosciences, Inc.

Completed
893 enrolled
Head & Neck

Gingival Neoplasms, Leukoplakia, Oral, Lip Neoplasms, Oropharyngeal Neoplasms, Palatal Neoplasms, Tongue Neoplasms, Oral Ulcer

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

RxKinetix

Phase 2 Completed
110 enrolled
Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡